Medipath DR
Medipath DR is a privately held molecular pathology laboratory in Santiago, Dominican Republic, serving thousands of medical offices with cytology, HPV testing, immunohistochemistry, PCR, and flow cytometry diagnostics billed through ARS insurers.
- Company typePrivate
- Founded2004
- HeadquartersSantiago de los Caballeros, Santiago, Dominican Republic
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Medipath DR does
Medipath DR (legal name: Laboratorios MediPath, trade name: MediPath - Instituto de Patología Molecular) is a privately held molecular pathology and diagnostic laboratory headquartered in Santiago de los Caballeros, Dominican Republic, founded in 2004 by Dra. Argelia Aybar. The company operates as a B2B laboratory service provider, processing specimens referred by physicians and clinics across the Dominican Republic. Its core technology portfolio spans cytology (ThinPrep liquid-based cytology with the country's first ThinPrep Integrated Imager, installed in 2011), HPV molecular testing (DNA-based Captura Híbrida/Cervista plus mRNA-based Aptima), immunohistochemistry (100+ markers), real-time PCR, flow cytometry for hematopathology, NAAT-based STI panels, and cytology/biopsy processing. Service delivery is supported by a digital ecosystem comprising the MediApp online results portal, the Pathy WhatsApp-based virtual assistant, and the EduPath continuing medical education platform.
The company earns revenue through transaction fees for diagnostic services, billed primarily through affiliations with five Dominican ARS insurers (SENASA, ARS Primera, Humano Seguros, ARS Yunen, Seguros Universal) and direct billing to patients for uninsured cases. Its go-to-market is sales-led, centered on direct relationships with referring physicians — particularly gynecologists, obstetricians, and oncology specialists — supported by in-house logistics for specimen pickup and a five-branch physical footprint (Santiago HQ, Santo Domingo, San Pedro de Macorís, La Vega, Puerto Plata) that provides nationwide coverage. The company also acts as the in-country distributor for Myriad Genetics (since 2018) and CELBREA (since 2022) genetic and diagnostic tests, layering representation income on top of its own laboratory operations.
Medipath DR firmographics
Firmographics- Name
- Medipath DR
- Legal name
- Laboratorios MediPath
- Website
- https://medipath.net
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Medipath DR is a privately held molecular pathology laboratory in Santiago, Dominican Republic, serving thousands of medical offices with cytology, HPV testing, immunohistochemistry, PCR, and flow cytometry diagnostics billed through ARS insurers.
- Ownership category
- akta.pro rank
Medipath DR industry classification
Industry- Product category
- Diagnostic Pathology Laboratory Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays) (HLAAALAI)
- akta.pro secondary industries
- Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Cell-Based & Potency Assays (Bioassays) (HLAGADAH), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)
Keywords
Where Medipath DR is headquartered
LocationHeadquarters
- HQ city
- Santiago de los Caballeros, Santiago
- HQ country
- Dominican Republic
- HQ region
- Latin America
Offices5 records
Markets served
Medipath DR business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Laboratory Diagnostic Services: Pathology and molecular diagnostic testing services billed through insurance providers (ARS) and direct patient payments. Services include cytology, biopsies, molecular testing, immunohistochemistry, and flow cytometry.
- Insurance/ARS Billing: Multiple affiliated insurance providers (SENASA, ARS Primera, Humano Seguros, ARS Yunen, Seguros Universal) process claims for covered diagnostic services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Insurance-covered diagnostic services |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Medipath DR product offering
Product offeringCore offering
Medipath is a molecular pathology laboratory that provides diagnostic testing services including cervical cancer screening (ThinPrep liquid-based cytology, HPV DNA and Aptima mRNA testing), immunohistochemistry panels (100+ markers), flow cytometry for hematopathology, real-time PCR for oncogenes and microorganisms, and STI panels using NAAT technology. Services are offered to healthcare providers across the Dominican Republic with specimens collected from medical offices and transported to the central laboratory for processing and reporting.
Product overview
Medipath is a molecular pathology laboratory offering a comprehensive portfolio of diagnostic tests and services for healthcare providers and patients. The core offering centers on cervical cancer screening through ThinPrep liquid-based cytology and HPV testing (including VPH Aptima mRNA detection and DNA-based methods), complemented by immunohistochemical cancer markers and molecular diagnostics. The laboratory provides real-time PCR for oncogenes and pathogens, flow cytometry for hematopathology, and combined STI panels. The service portfolio includes physical pathology services (biopsies, cytology, staining), molecular diagnostics, and digital services (MediApp for result access and EduPath for physician education). The company operates as a single integrated laboratory with multiple service lines rather than a modular platform architecture.
Differentiator
Problem solved
Functional benefit
Brands
- EduPath: Continuing medical education platform offering an integral series of educational programs for healthcare professionals.
- MediApp
Products and services
- ThinPrep Liquid-Based Cytology FDA-approved liquid-based cervical cytology test for detecting alterations in cervical cells with higher sensitivity than traditional Pap smears; processed with the ThinPrep Integrated Imager. Targeted at gynecologists and obstetricians.
- HPV DNA Testing (Hybrid Capture and Cervista)
Quantifiable outcome
- ThinPrep reduces false negatives compared to traditional Pap smear
- +2 more outcomes
Companies that use Medipath DR
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles2 records
Medipath DR technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Medipath DR partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- CELBREAcoreCELBREA representation partnership established in 2022. Medipath serves as authorized distributor for CELBREA diagnostic products in Dominican Republic.
- Myriad GeneticscoreMyriad Genetics representation agreement in Dominican Republic. Medipath serves as the authorized representative for Myriad's genetic testing services including hereditary cancer testing and companion diagnostics in the Dominican market.
Scale indicators5 records
Recent moves18 records
Expansion highlights5 records
Medipath DR competitors and assessment
Company assessmentBroad incumbents
- Quest Diagnostics: Global clinical laboratory network providing routine and advanced molecular diagnostics to physicians and hospitals. Comparable to Medipath in physician-focused B2B laboratory services and broad test menu, though at vastly larger scale and geographic reach.
- Hologic: Global diagnostics and medical device company whose ThinPrep liquid-based cytology platform is core to Medipath's cervical cancer screening offering. Comparable as a technology supplier and adjacent diagnostics player, though Hologic operates at far greater scale and breadth.
- Myriad Genetics: US-based molecular diagnostics company specializing in hereditary cancer and companion diagnostics. Comparable to Medipath as a partner in advanced molecular diagnostics, with overlapping capabilities in oncology testing that Medipath distributes in the Dominican Republic.
- Synlab: Europe's largest medical diagnostics services provider offering clinical and specialty pathology across multiple countries. Comparable to Medipath in core laboratory services and physician-hospital channels, but operating at continental scale versus single-country.
- Mayo Clinic Laboratories: Reference laboratory arm of Mayo Clinic offering esoteric and molecular diagnostics to global clients. Comparable to Medipath's advanced molecular and pathology menu, with physicians sending cases for specialized testing — a model Medipath could replicate regionally.
Regional players
- ARUP Laboratories: US-based national reference laboratory known for esoteric and molecular diagnostics often serving as a referral lab. Comparable to Medipath's advanced molecular/hematopathology test menu and physician referral model, though primarily serves North America.
- Doctor's Clinical Laboratory: Caribbean-based clinical laboratory network serving physician practices and hospitals in the region. Comparable to Medipath in geography, customer base, and routine-plus-specialty testing portfolio.
Direct peers
- Amadita Laboratorio Clínico: Dominican Republic-based clinical laboratory offering a broad menu of diagnostic tests across the country. Directly comparable to Medipath as a fellow national lab network with multiple branches and B2B relationships with physicians and insurers.
- Referencia Laboratorio Clínico: Dominican Republic-based clinical laboratory serving physicians, hospitals, and patients nationwide. Comparable to Medipath in scale, multi-branch model, and physician-centric GTM across the same Dominican market.
- Patología Avanzada: Caribbean/regional specialty pathology laboratory focused on anatomic and molecular pathology services. Comparable to Medipath in test menu (biopsies, IHC, molecular diagnostics) and physician-office specimen workflow.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Medipath DR social profiles
Digital presenceMedipath DR financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medipath DR leadership team
Management profileNumber of profiles
Profiles1 record
Medipath DR funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medipath DR M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medipath DR
What does Medipath DR do?
Medipath is a molecular pathology laboratory that provides diagnostic testing services including cervical cancer screening (ThinPrep liquid-based cytology, HPV DNA and Aptima mRNA testing), immunohistochemistry panels (100+ markers), flow cytometry for hematopathology, real-time PCR for oncogenes and microorganisms, and STI panels using NAAT technology. Services are offered to healthcare providers across the Dominican Republic with specimens collected from medical offices and transported to the central laboratory for processing and reporting.
Is Medipath DR a public or private company?
Medipath DR is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Medipath DR founded?
Medipath DR was founded in 2004. It employs 11 to 50 people.
Where is Medipath DR based?
Medipath DR is headquartered in Santiago de los Caballeros, Santiago, Dominican Republic, in the Latin America region.
How does Medipath DR make money?
Two revenue lines are on record. Laboratory Diagnostic Services are the primary driver. The others are insurance/ARS Billing.
Who are Medipath DR's main competitors?
Broad incumbents on record are Quest Diagnostics, Hologic, Myriad Genetics, Synlab and Mayo Clinic Laboratories. Regional players are ARUP Laboratories and Doctor's Clinical Laboratory. Direct peers are Amadita Laboratorio Clínico, Referencia Laboratorio Clínico and Patología Avanzada.
Does Medipath DR have an API?
No public API is recorded for Medipath DR.
What industry is Medipath DR in?
Medipath DR's product category is Diagnostic Pathology Laboratory Services. Its primary akta.pro industry code is HLAAALAI, Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays), with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 621511 and its SIC code is 8071.